Print

Relypsa, Inc. to Present Phase 3 Data in Late-Breaking Poster Session at ASN Kidney Week 2013 Annual Meeting in Atlanta, GA  
10/21/2013 7:18:34 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Relypsa, Inc., a clinical-stage biopharmaceutical company, today announced that the American Society of Nephrology (ASN) has accepted its abstract for the late-breaking clinical trial poster session of the ASN Kidney Week 2013 Annual Meeting in Atlanta, GA.

Help employers find you! Check out all the jobs and post your resume.

//-->